Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Halton Group to strengthen its Executive Team

To enhance the implementation of its growth strategy and to improve the utilization of scale benefits in its operation, Halton Group announces two nominations in the group management, effective as of 1 September 2020.Halton Group’s current CFO Janne Pukkila will take on a new role as Director, Operational Excellence. In this task, he will focus on driving operational excellence improvements across Halton’s units, including promoting synergy benefits, operational efficiency and related common initiatives. In his new role, Janne Pukkila will continue to report to Group CEO Kai Konola.

Change in Zengun Group AB’s management

Anna-Carin Bjelkeby, CFO of Zengun Group AB (publ) is stepping down at her own request. She will remain in the role until 31 August. Stefan Lindh, who is currently employed at the Group as Financial Controller, has been appointed the new CFO. Stefan is one of the founders of Zengun and has previously been responsible for the company’s finances.  “Anna-Carin’s work is highly appreciated, her wealth of experience with financial reporting and financing as well as her experience of the stock exchange have contributed to Zengun Group’s strong and stable financial position. I would like to

Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA[®] in mesothelioma

· Targovax to collaborate in a randomized phase II trial investigating the combination  ONCOS-102, Keytruda and standard of care chemotherapy in first line malignant pleural mesothelioma Oslo, Norway, 23 June 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that it has entered into a collaborative agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada) with the intent to initiate a randomized phase II trial to evaluate the combination of ONCOS-

Successful restart of A-ROSA River Cruises

A-ROSA resumes voyages across all rivers and extends its early-booking-discounts for 2021Rostock, 22 June 2020 – After a successful restart of its Douro sailings in Portugal, A-ROSA River Cruises recommenced its cruises on the Rhine river on 17 June 2020 and on the Danube on 20 June 2020. The resumption of A-ROSA’s French operation will take place on 11 July 2020. "We are delighted to be cruising again on Europe’s most beautiful rivers. Naturally, we eagerly awaited feedback from the first guests that we welcomed on board. We are thrilled that it was very positive. It paid off to

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

June 22, 2020 - On May 19, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of May 19, 2020. According to the programme, Asetek A/S will in the period until September 30, 2020 buy back own shares up to a maximum value of USD 4.5 million and with a maximum of 1,038,082 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 15% of the total share amount

Scandion Oncology A/S (“Scandion Oncology”) announces that Saniona has reduced its ownership stake in Scandion Oncology A/S to below 15%. Saniona, together with CEO Nils Brünner and CSO Jan Stenvang initially founded Scandion Oncology A/S in 2017. After the last capital raise in June 2019, Saniona owned approximately 18% of Scandion Oncology. Proceeds from sales of shares will be used to continue Saniona’s advancement of their pipeline, including mid/late-stage clinical trials with Tesomet.Nils Brünner, CEO of Scandion Oncology says: “We are very grateful for the constructive and valuable

The Nomination Committee proposes new election of Anna Tenstam as ordinary Board member of Peptonic Medical

Stockholm, June 22, 2020. - Peptonic Medical AB (publ) ("The Company" or "Peptonic") - today announces that the Nomination Committee proposes that Anna Tenstam be elected to the Board. Furthermore, Hans von Celsing, Leni Ekendahl and Marianne Östlund are re-elected as members with Hans von Celsing as chairman. Arne Ferstad has declined re-election. The meeting will be held on June 30 in Stockholm.The Nomination Committee proposes that the members receive SEK 75,000 in remuneration per year and that the Chairman receive SEK 150,000. The Nomination Committee has been appointed on the basis

New Swedish patent approval for Episurf Medical

The Swedish patent office PRV has announced its intention to grant another Swedish patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “An implant for cartilage and/or bone repair”, is within the area of joint implant materials and implant features.  “This is a patent covering combinations of implant bulk and coating materials, to protect specific features of Episurf’s Episealer® technology. We are happy for this first approval of this patent family”, says Katarina Flodström, COO, Episurf Medical.     For more information, please contact: Pål Ryfors, CEO, Episurf

Stillfront publishes approved bond prospectus and applies for listing of bonds on Nasdaq Stockholm

Press release22 June, 2020Stillfront Group AB (publ) has today applied for listing of its SEK 1,000 million senior unsecured floating rate bonds due 2024 (ISIN:0012728830) on Nasdaq Stockholm's Corporate Bond List. The first day of trading on Nasdaq Stockholm is expected to be on Wednesday 24 June 2020. For the purpose of the listing of the bonds, the company has prepared a prospectus that has today been approved by and registered with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available on Stillfront’s corporate website https://www.

RNB subsidiaries apply to extend company reorganisations

RNB Retail and Brands AB (publ) subsidiaries have today to the Stockholm District Court applied to extend their ongoing company reorganisations (Sw. företagsrekonstruktioner). In the same applications the Companies petitioned a deferral to, and including, July 1, 2020 to complete the applications. By that date at the latest, the companies will present settlement proposals to the creditors. With the applications the companies’ company reorganisations continue until a formal decision to extend has been made by the District Court.

EAB GROUP PLC: ACQUISITION OF OWN SHARES 22.06.2020

EAB GROUP PLC NOTIFICATION 22.06.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 22.06.2020 Date 22.06.2020Exchange transaction BuyShare class EABAmount 1,170Average price/share 2.1600 EURHighest price/share 2.1600 EURLowest price/share 2.1600 EURTotal price 2,527.20 EUR The shares held by EAB Group Plc on 22.06.2020: EAB 25,997 On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

#20-215 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-214 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Zutec Holding AB announces outcome in the rights issue and the new issue of shares to the public

Following the end of the subscription period ending 15 June 2020 of Zutec Holding AB’s ("Zutec" or "the Company") fully guaranteed rights issue of approximately SEK 40.4 million (the “Rights Issue”) and new issue of shares to the public of Sweden and Ireland of approximately SEK 2 million (the “Directed Issue”) (together the “Offer”), the Company today announces the outcome of the Offer. The Rights Issue was subscribed for a 66,47 per cent with subscription rights. Additionally, 33,53 per cent of the Rights Issue was subscribed without subscription rights. The total demand in the Rights

RhoVac receives approval in Sweden to start clinical phase IIb trial

RhoVac AB ("RhoVac") announces today, on June 22[nd], 2020, that the company has received approval from all regulatory authorities in Sweden, which means that the clinical IIb study in prostate cancer ("BRaVac") can also be started in Sweden. The clinical phase IIb trial is an international study that is expected to recruit at least 175 patients in six European countries (Denmark, Finland, Sweden, the United Kingdom, Belgium and Germany) as well as in the United States.BRaVac is a randomized, placebo-controlled and double-blind study, with the primary study aim to evaluate whether treatment

DreamHack in agreement with Epic Games on new Fortnite tournament series

STOCKHOLM, June 22nd 2020 — Modern Times Group MTG AB’s (publ.) (“MTG”) esports portfolio company DreamHack has today announced the launch of a new tournament series featuring Fortnite following the entering in a new agreement with Epic Games. The tournament – with a monthly prize pool of USD 250,000 and a total of USD 1.75 million - will to be broadcasted live on Twitch.“DreamHack has a unique standing and position in the global gaming and esports community, and we are very pleased to see yet another leading publisher acknowledge this by trusting them with production of their esports

ABS Chairman, President and CEO Delivers Inspirational Message to USMMA Graduates during Historic Academy Commencement

Christopher J. Wiernicki Offers Leadership Insight Drawn from Remarkable Family History(KINGS POINT) – “Remember that deeds not words will get the ships through.”That was the message from Christopher J. Wiernicki, ABS Chairman, President and CEO as the Distinguished Industry Speaker for 210 graduating cadets at the U.S. Merchant Marine Academy’s first semi-virtual graduation ceremony, which was closed to the public but livestreamed.“I realize this is not the graduation ceremony any of you pictured in your minds, but nothing, not even a global pandemic, can change what you have

DreamHack Announces DreamHack Open Featuring Fortnite Tournament Series

Live Coverage to be Produced by DreamHack on TwitchSTOCKHOLM — DreamHack , the premier gaming lifestyle festival, announces the launch of a new tournament series featuring Fortnite.  The series — entitled DreamHack Open Featuring Fortnite — will kick off in July and consists of monthly online tournaments for the EU, NA East, and NA West Fortnite servers through all of 2020, and will be broadcast live on Twitch .  A total of $1.75 million USD will be awarded in 2020 — a prize pool of $250,000 will be up for grabs every month.   “

Henrik Ljung will take the role of Chief Financial Officer, CFO, in Qlife Holding AB.

Henrik Ljung holds an MBA from Lund’s university and has extensive experience as CFO in listed companies such as Spectracure AB, Acconeer AB and AB Sardus. He will be part of Qlife Holdings' management and report directly to CEO Thomas Warthoe."Henrik Ljung brings broad experience to Qlife from financial reporting, IR, business control, finance management and corporate governance, all with a focus on fast-growing companies in the early stages. It is with great pleasure that I welcome Henrik to our company," says Thomas Warthoe, CEO of Qlife Holding. "I look forward to joining Qlife and

CONCLUSION OF 2017 WARRANT PROGRAM

The annual general meeting (AGM) of May 19, 2017 approved a warrant program for company personnel whose subscription period ended on June 20, 2020. A total of 454,000 warrants were issued.  In accordance with the program terms and conditions, the final adjusted subscription price was SEK 27.40 per share and the conversion ratio was set to 1.022 new shares per warrant. The warrant parameter adjustments were a result of the rights issue announced on October 31, 2017. No new shares were subscribed through the warrant program.For more information contact: Marie Dhayer Teikmans, CFO

Neonode Touch Sensor Modules Selected for Touchless Holographic Products by Yesar

STOCKHOLM, SWEDEN, June 22, 2020 — Neonode Inc. (NASDAQ: NEON), is pleased to announce that its touch sensor modules have been selected by Yesar Electronics Technology (Shanghai) Co. Ltd. (“Yesar”) for a range of products with holographic interfaces. Yesar is ramping production to deliver several thousand holographic elevator control panels in the second half of 2020. Additional contactless products are under development at Yesar, including kiosks and gaming applications.Yesar CEO Darcy Shi said, “We are seeing tremendous demand for our holographic solutions in several product categories.

Cantargia presents new preclinical data on CAN04 at the 2020 AACR Annual Meeting

· Both parts of the IL-1 system are upregulated in tumor tissue after chemotherapy · CAN04, blocking the activity of both forms of IL-1, increases the efficacy of several different chemotherapy regimes Cantargia AB (“Cantargia”) today presented new preclinical data giving additional knowledge around the mechanisms and thereby relevance of adding the clinical stage antibody CAN04 to chemotherapy. CAN04 combined with different chemotherapy regimens resulted in additive or synergistic antitumor effects and the results were presented at the 2020 Annual Meeting of the American Association

According to a recent study ecological packaging material is an increasingly important factor in consumers’ purchasing decisions

Metsä Board Corporation press release 22.06.2020According to the LOHAS2020 study, a growing number of consumers are considering the consequences of their consumption behaviour. Up to two out of three Finnish consumers would like to have more information on which packaging would be the best choice for both the environment and the shelf life of the product. “This was the third LOHAS consumer survey to address packaging issues extensively. Compared to previous studies conducted in 2011 and 2014, a lifestyle that supports both personal health and sustainable development has become an

FIRST PHASE OF WEST CARCLAZE GARDEN VILLAGE IN CORNWALL SECURES £18M FUNDING AS DEVELOPERS LOOK TO CREATE "BEST PLACE TO LIVE IN THE UK"

· New Garden Village on the outskirts of St Austell in Cornwall focused on delivering sustainable community living · The developer, Eco-Bos, is a joint venture between Imerys and Orascom Development Holdings, a specialist in the development of fully integrated sustainable developments · The first phase will deliver 270 new homes, with up to 1,500 planned over the course of the entire development · £18m development finance facility from Shawbrook Bank will support the first phase of this unique schemeNEWS RELEASE: Monday, June 22[nd], 2020 West Carclaze Garden Village on the

There are no items matching the current filter
There are no more items matching the current filter
Back to top